Maas, J W; Bowden, C L; Miller, A L et al. (1997) Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations. Schizophr Bull 23:147-54 |
Miller, A L; Maas, J W; Contreras, S et al. (1993) Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Biol Psychiatry 34:178-87 |
Maas, J W; Contreras, S A; Miller, A L et al. (1993) Studies of catecholamine metabolism in schizophrenia/psychosis--I. Neuropsychopharmacology 8:97-109 |
Maas, J W; Contreras, S A; Miller, A L et al. (1993) Studies of catecholamine metabolism in schizophrenia/psychosis--II. Neuropsychopharmacology 8:111-6 |
Rogeness, G A; Javors, M A; Maas, J W et al. (1990) Catecholamines and diagnoses in children. J Am Acad Child Adolesc Psychiatry 29:234-41 |
Rogeness, G A; Maas, J W; Javors, M A et al. (1989) Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res 27:241-51 |
Rogeness, G A; Maas, J W; Javors, M A et al. (1988) Diagnoses, catecholamine metabolism, and plasma dopamine-beta-hydroxylase. J Am Acad Child Adolesc Psychiatry 27:121-5 |
Maas, J W; Contreras, S A; Seleshi, E et al. (1988) Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin. Arch Gen Psychiatry 45:553-9 |
Miller, A L; Keenan, R W; Maas, J W et al. (1987) Disposition of homovanillic acid in the primate. Metab Brain Dis 2:207-12 |
Rogeness, G A; Javors, M A; Maas, J W et al. (1987) Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys. Biol Psychiatry 22:1158-62 |
Showing the most recent 10 out of 11 publications